Upper respiratory tract infections: Etiology, current treatment, and experience with fluoroquinolones

Clinical Microbiology and Infection

Volumn 4, Issue SUPPL. 2, 1998, Pages 2S51-2S58

  Garau, Javier ^a   Barry, Beatrix ^b   Butzler, Jean Paul ^c   Dagan, Ron ^d   Pelton, Stephen I ^e  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b BICHAT HOSPITAL   (France)

^c SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

CHRONIC OTITIS MEDIA; CONFERENCE PAPER; DISEASE CARRIER; HUMAN; IMMUNE DEFICIENCY; OTITIS MEDIA; PRIORITY JOURNAL; SINUSITIS; UPPER RESPIRATORY TRACT INFECTION;

EID: 7144242338     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00694.x     Document Type: Conference Paper

References (46)

1. Schwartz R. The diagnosis and management of sinusitis. Nurse Pract 1994; 19: 58-63.
2. Chow JM. The diagnosis and management of sinusitis. Compr Ther 1995; 21: 74-9.
3. Van Cauwenberge PB, Vander Mijnsbrugge AM, Ingels KJA. The microbiology of acute and chronic sinusitis and otitis media. Eur Arch Otorhinolaryngol 1993; 250(suppl): 3-6.
4. Nava JM, Bella F, Garau J, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population based study. Clin Infect Dis 1994; 19: 884-90.
5. Baquero F. Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. J Antimicrob Chemother 1996; 38(suppl A): 117-32.
6. Von Sydow C, Savolainen S, Söderqvist A. Treatment of acute maxillary sinusitis - comparing cefpodoxime proxetil with amoxicillin. Scand J Infect Dis 1995; 27: 229-34.
7. Goldstein FW, Acar JF, the Alexander Project collaborative group. Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of 1992-93 Western Europe and USA collaborative surveillance study. J Antimicrob Chemother 1996, 38(suppl A): 71-84.
8. Linares J, Tubau FE, Alcaide F, Ardany C, Garcia A, Martin R. Antimicrobial resistance of S. pneumoniae: comparison of the in vitro activity of 16 antibiotics. Curr Ther Res 1996; 57(suppl A): 57-64.
9. Goldstein F, Garau J. Resistant pneumococci: a renewed threat in respiratory infections. Scand J Infect Dis 1994; 93(suppl): 55-62.
10. Dagan R, Leibovitz E, Jacobs M, et al. Bacteriologic response to acute otitis media caused by Haemaphilus influenzae treated by azithromycin [abstract K102]. In: 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington DC: American Society for Microbiology, 1997: 345.
11. Howie VM. Eradication of bacterial pathogens from middle ear infection. Clin Infect Dis 1992; 14(suppl 2): 209-10.
12. Gehanno P, Berche P, the Sinusiris Study Group. Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. J Antimicrob Chemother 1996; 37: 105-14.
13. Husfeldt P, Egede F, Nielsen PB. Antibiotic treatment of sinusitis in general practice: a double-blind study comparing ofloxacin and erythromycin. Eur Arch Otorhinolaryngol 1993; 250(suppl 1): S23-5.
14. Adelglass J, DeAbate CA, McElvaine P, Fowler CL. A comparison of levofloxacin and amoxicillin/clavulanate for the treatment of acute bacterial sinusitis in adults. Clin Infect Dis 1996; 23: 913.
15. Sydnor A, Kopp EJ, Anthony K, Fowler CL. A multicenter, noncomparative study to evaluate the safety and efficacy of oral levofloxacin (LVFX) in the treatment of acute sinusitis in adults. J Allergy Asthma Immunol 1997; 78: 125.
16. Sydnor TA, Scheid WM, Gwaltney JM. A noncomparative study to evaluate the safety and efficacy of levofloxacin in the treatment of acute bacterial sinusitis in adults. Poster Presentation, 19th International Congress of Chemotherapy, Montreal, Canada, 1995.
17. Lockey RF. Management of chronic sinusitis. Hosp Pract 1996; 31: 141-51.
18. Brook I, Thompson DH, Frazier EH. Microbiology and management of chronic maxillary sinusitis. Arch Otolaryngol Head Neck Surg 1994; 120: 1317-20.
19. Sener B, Hasçelik G, Önerci M, Tunçkanat F. Evaluation of the microbiology of chronic sinusitis. J Laryngol Otol 1996; 110: 547-50.
20. Fombeur JP, Barrault S, Koubbi G, et al. Study of the efficacy and safety of ciprofloxacin in the treatment of chronic sinusitis. Chemotherapy 1994; 40(suppl 1): 248.
21. Legent F, Bordure PH, Beauvillain C, Berche P. A double blind comparison of ciprofloxacin and amoxycillin/clavulanic acid in the treatment of chronic sinusitis. Chemotherapy 1994; 40(suppl 1): 8-15.
22. Gehanno P, Cohen B. Effectiveness and safety of ofloxacin in chronic otitis media and chronic sinusitis in adult outpatients. Eur Arch Otorhinolaryngol 1993; 250(suppl 1): S13-14.
23. Gaillot O, Berche P. In vitro susceptibility to ciprofloxacin of bacterial strains isolated from chronic otitis media and chronic sinusitis. Drugs 1995; 49(suppl 2): 200-2.
24. Fish DN, Chow AT. The clinical pharmacokinerics of levofloxacin. Clin Pharmacokinet 1997; 32: 101-19.
25. Wise R, Honeybourne D. A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses. J Antimicrob Chemother 1996, 37(suppl A): 57-63.
26. Petrikkos G, Goumas P, Moschovakis E, Giamarellou H. Penetration of pefloxacin into maxillary sinus cavity and nasal secretions. Eur J Clin Microbiol Infect Dis 1992; 11: 828-31.
27. Schappert SM. Vital Statistics and Health Statistics of the Centers for Disease Control/National Center for Health Statistics. Washington DC: US Department of Health and Human Services, 1992; 214: 1-18.
28. Ruuskanen O, Heikkinen T. Otitis media: etiology and diagnosis. Pediatr Infect Dis J 1994; 13(suppl): S23-6.
29. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in Greater Boston: a prospective, cohort study. J Infect Dis 1989; 160: 83-94.
30. Del Castillo F, Garcia-Perea A, Baquero-Artigao F. Bacteriology of acute otitis media in Spain: a prospective study based on tympanocentesis. Pediatr Infect Dis J 1996; 15: 541-3.
31. Bluestone CD, Stephenson JS, Martin LM. Ten year review of otitis media pathogens. Pediatr Infect Dis 1992; 11: S7-11.
32. Ogawa H, Hashiguch K, Kazuyama Y. Isolation of Chlamydia trachomatis from the middle ear aspirates of otitis media. Acta Otolaryngol (Stockh) 1990; 110: 105-9.
33. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant S. pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis 1995; 14: 751-9.
34. Leibovitz E, Dagan R. Oral cephalosporins in upper respiratory infections. In Moellering RC, ed. Antibiotic chemotherapy. Basel: Karger, 1995: 110-22.
35. Dagan R, Abramson O, Leibovitz E, et al. Impaired response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis 1996; 15: 980-5.
36. Dagan R, Abramson O, Leibovitz E, et al. Bacteriological response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J Infect Dis 1997; 176: 1253-9.
37. Pessey JJ, the multicentre group. Etude de l'efficacité et de la tolérance de l'ofloxacine en solution auriculaire dans la suppuration des cavités d'évidement et la préparation préopératoire des otites chroniques non ostéïtiques. Rev Offic Soc Fr ORL 1996; 40: 45-51.
38. Sumitsawan Y, Tharavichitkul P, Prawatmuang W, Ingsuwan B, Sriburi P. Ofloxacin otic solution as treatment of chronic suppurative otitis media and diffuse bacterial otitis externa. J Med Assoc Thai 1995; 78: 455-9.
39. Tong MC, Woo JK, van Hasselt CA. A double-blind comparative study of ofloxacin otic drops versus neomycin-polymyxin B-hydrocortisone otic drops in the medical treatment of chronic suppurative otitis media. J Laryngol Otol 1996; 110: 309-14.
40. Yuen PW, Lau SK, Chau PY, et al. Ofloxacin eardrop treatment for active chronic suppurarive otitis media: prospective randomized study. Am J Otol 1994; 15. 670-3.
41. Canafax DM, Russlie HQ, Lovdahl MJ, Giebink GS. Ciprofloxacin middle ear and plasma pharmacokinetics in experimental acute otitis media. In Lim DJ, Bluestone CD, Casselbrant M, et al, eds. Recent advances in otitis media. Hamilton, Ontario: BC Decker Inc., 1996: 241-3.
42. Baba S, Miyamoto N, Yanai O, et al. Study on the penetration of levofloxacin (DR-3355) into the otorhinolaryngeal tissues and discharges in patients. Chemotherapy 1992; 40(suppl 3): 326-33.
43. Lang R, Goshen S, Raas-Rothschild A, et al. Oral ciprofloxacin in the management of chronic suppurative otitis media without cholesteatoma in children: preliminary experience in 21 children. Pediatr Infect Dis J 1992; 11: 925-9.
44. Vukmir RB. Adult and pediatric pharyngitis: a review J Emerg Med 1992; 10: 607-16.
45. Falck G, Heyman L, Gnarpe J, Gnarpe H. Chlamydia pneumoniae and chronic pharyngitis. Scand J Infect Dis 1995; 27: 179-82.
46. Marx MA, Fant WK. Cefuroxime axetil. Drug Intell Clin Pharm 1988; 22: 641-8.